Saturday, November 14, 2026

EUR/CHF Bearish Momentum: 0.87% Down In The Last 5 Sessions

ViaNews Editorial Team

February 6, 2023

Automated market report from our archive (2020–2024), published before source-traceability. How we work

EUR/CHF Bearish Momentum: 0.87% Down In The Last 5 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 0.87% for the last 5 sessions. At 05:06 EST on Monday, 6 February, EUR/CHF (EURCHF) is $1.00.

EUR/CHF's yearly highs and lows, it's 5.557% up from its 52-week low and 6.201% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.45%, a positive 0.02%, and a positive 0.29%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.45% (last week), 0.34% (last month), and 0.29% (last quarter), respectively.

News about

  • According to FXStreet on Sunday, 5 February, "Following the news, the USD/JPY pair defends Friday's recovery moves around 131.85, up nearly half a percent intraday."
  • Usd/jpy price analysis: renews three-week high but 50-dma probes bulls. According to FXStreet on Monday, 6 February, "If at all the USD/JPY bears manage to conquer the 128.20 support bottom surrounding 127.20 and May 2022 low near 126.35 could probe them before highlighting the 120.00 round figure.", "Following that, an ascending trend line from mid-January will challenge the USD/JPY sellers around 128.20."
  • Usd/jpy eases from multi-week top, bullish potential intact amid post-nfp USD strength. According to FXStreet on Monday, 6 February, "Apart from this, the broader risk sentiment will drive demand for the safe-haven JPY and contribute to producing short-term opportunities around the USD/JPY pair.", "The prevalent risk-off environment - as depicted by a generally weaker tone around the equity markets - underpins the safe-haven Japanese Yen (JPY) and acts as a headwind for the USD/JPY pair. "
  • Usd/jpy: the ingredients are in place for a renewed move lower – HSBC. According to FXStreet on Monday, 6 February, "A move lower in USD/JPY over the coming few weeks will mostly rely on the outlook for BoJ policy change, but other more medium-term forces (such as improving current account balance) should also be helping in the background."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com